Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Resuscitation ; 82(3): 341-9, 2011 Mar.
Article in English | MEDLINE | ID: mdl-21168947

ABSTRACT

OBJECTIVE: The study investigated a possible neuroprotective potency of minocycline in an experimental asphyxial cardiac arrest (ACA) rat model. Clinically important survival times were evaluated thus broadening common experimental approaches. METHODS: Adult rats were subjected to 5 min of ACA followed by resuscitation. There were two main treatment groups: ACA and sham operated. Relating to minocycline treatment each group consisted of three sub-groups: pre-, post-, and sans-mino, with three different survival times: 4, 7, and 21 days. Neurodegeneration and microgliosis were monitored by immunohistochemistry. Alterations of microglia-associated gene expression were analyzed by quantitative RT-PCR. RESULTS: ACA induced massive nerve cell loss and activation of microglia/macrophages in hippocampal CA1 cell layer intensifying with survival time. After 7 days, minocycline significantly decreased both, neuronal degeneration and microglia response in dependence on the application pattern; application post ACA was most effective. After 21 days, neuroprotective effects of minocycline were lost. ACA significantly induced expression of the microglia-associated factors Ccl2, CD45, Mac-1, F4-80, and Tnfa. Independent on survival time, minocycline affected these parameters not significantly. Expression of iNOS was unaffected by both, ACA and minocycline. CONCLUSIONS: In adult rat hippocampus microglia was significantly activated by ACA. Minocycline positive affected neuronal survival and microglial response temporary, even when applied up to 18 h after ACA, thus defining a therapeutically-relevant time window. As ACA-induced neuronal cell death involves acute and delayed events, longer minocycline intervention targeting also secondary injury cascades should manifest neuroprotective potency, a question to be answered by further experiments.


Subject(s)
Asphyxia/pathology , Heart Arrest/complications , Hippocampus/pathology , Minocycline/therapeutic use , Animals , Asphyxia/drug therapy , Asphyxia/etiology , Biomarkers/analysis , Brain/pathology , Brain Ischemia/drug therapy , Cell Death , Disease Models, Animal , Immunohistochemistry , Microglia/pathology , Minocycline/pharmacology , RNA, Messenger/analysis , Rats , Resuscitation , Reverse Transcriptase Polymerase Chain Reaction , Time Factors
2.
BMC Mol Biol ; 9: 53, 2008 May 28.
Article in English | MEDLINE | ID: mdl-18505597

ABSTRACT

BACKGROUND: Cardiac arrest, and the associated arrest of blood circulation, immediately leads to permanent brain damage because of the exhaustion of oxygen, glucose and energy resources in the brain. Most hippocampal CA1 neurons die during the first week post the insult. Molecular data concerning the recovery after resuscitation are sparse and limited to the early time period. Expression analysis of marker genes via quantitative real-time RT-PCR enables to follow up the remodeling process. However, proper validation of the applied normalization strategy is a crucial prerequisite for reliable conclusions.Therefore, the present study aimed to determine the expression stability of ten commonly used reference genes (Actb, actin, beta; B2m, beta-2 microglobulin;CypA, cyclophilin A; Gapdh, glyceraldehyde-3-phosphate dehydrogenase; Hprt, hypoxanthine guanine phosphoribosyl transferase; Pgk1, phosphoglycerate kinase 1; Rpl13a, ribosomal protein L13A; Sdha, succinat dehydrogenase complex, subunit a, flavoprotein (Fp); Tbp, TATA box binding protein; Ywhaz, tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide) in the rat hippocampus four, seven and twenty-one days after cardiac arrest. Moreover, experimental groups treated with the anti-inflammatory and anti-apoptotic drug minocycline have been included in the study as well. RESULTS: The microglial marker Mac-1, used as a target gene to validate the experimental model, was found to be upregulated about 10- to 20-fold after cardiac arrest. Expression stability of candidate reference genes was analyzed using geNorm and NormFinder software tools. Several of these genes behave rather stable. CypA and Pgk1 were identified by geNorm as the two most stable genes 4 and 21 days after asphyxial cardiac arrest, CypA and Gapdh at 7 days post treatment. B2m turned out to be the most variable candidate reference gene, being about 2-fold upregulated in the cardiac arrest treatment groups. CONCLUSION: We have validated endogenous control genes for qRT-PCR analysis of gene expression in rat hippocampus after resuscitation from cardiac arrest. For normalization purposes in gene profiling studies a combination of CypA and Pgk1 should be considered 4 and 21 days post injury, whereas CypA and Gapdh is the best combination at 7 days. CypA is most favorable if restriction to a single reference gene for all time points is required.


Subject(s)
Heart Arrest/genetics , Reverse Transcriptase Polymerase Chain Reaction/methods , 14-3-3 Proteins , Actins/genetics , Animals , Cyclophilin A/genetics , Disease Models, Animal , Flavoproteins/genetics , Gene Expression Profiling , Glyceraldehyde-3-Phosphate Dehydrogenases/genetics , Heart Arrest/metabolism , Hippocampus/metabolism , Hypoxanthine Phosphoribosyltransferase/genetics , Immunohistochemistry , Male , Microtubule-Associated Proteins/analysis , Molecular Chaperones/genetics , Phosphoglycerate Kinase/genetics , Rats , Rats, Wistar , Ribosomal Proteins/genetics , Succinate Dehydrogenase/genetics , TATA-Box Binding Protein/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...